Latest Period
Q1 2026
Security Snapshot
Nanobiotix S.A. - Common Stock (NBTX) Institutional Ownership
CUSIP: 63009J107
13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026
Institutions Reporting
15
Shares (Excl. Options)
5,698,109
Price
$30.87
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- NBTX on Nasdaq
- Shares outstanding
- 46,821,220
- Price per share
- $33.71
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 5,698,109
- Total reported value
- $175,900,273
- % of total 13F portfolios
- 0%
- Share change
- -2,736
- Value change
- +$46,423
- Number of holders
- 15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- NBTX - Nanobiotix S.A. - Common Stock is tracked under CUSIP 63009J107.
- 15 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 14 to 15 between Q4 2025 and Q1 2026.
- Reported value moved from $131,804,789 to $175,900,273.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 15 institutions filings for Q1 2026.
Security key
63009J107
Latest holder period
Q1 2026
13F holders
15
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
NBTX full holder history
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 63009J107:
Significant Owners of Nanobiotix S.A. - Common Stock (NBTX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 8.9% | $13,545,053 | 4,232,829 | Invus Public Equities, L.P. | 31 Dec 2023 | |||
| BAILLIE GIFFORD & CO | 4.1% | $6,142,944 | 1,919,670 | BAILLIE GIFFORD & CO | 31 Dec 2024 |
As of 31 Mar 2026, 15 institutional investors reported holding 5,698,109 shares of Nanobiotix S.A. - Common Stock (NBTX). This represents 12% of the company’s total 46,821,220 outstanding shares.
Top 16 Institutional Shareholders
The largest institutional shareholders of Nanobiotix S.A. - Common Stock (NBTX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 12% | 5,623,816 | 0% | 27% | $173,607,200 |
| MORGAN STANLEY | 0.08% | 36,274 | +58% | 0% | $1,119,778 |
| Optiver Holding B.V. | 0.03% | 13,501 | -17% | 0.02% | $416,776 |
| MARSHALL WACE, LLP | 0.02% | 9,239 | -2.7% | 0% | $285,207 |
| UBS Group AG | 0.01% | 5,557 | +263% | 0% | $171,545 |
| BNP PARIBAS FINANCIAL MARKETS | 0.01% | 3,559 | 0% | 0% | $109,866 |
| RHUMBLINE ADVISERS | 0% | 2,281 | -2.6% | 0% | $70,409 |
| ROYAL BANK OF CANADA | 0% | 1,825 | -30% | 0% | $56,000 |
| GAMMA Investing LLC | 0% | 828 | +262% | 0% | $25,560 |
| EverSource Wealth Advisors, LLC | 0% | 514 | 0% | 0% | $15,867 |
| OSAIC HOLDINGS, INC. | 0% | 500 | 0% | 0% | $15,435 |
| WELLS FARGO & COMPANY/MN | 0% | 200 | 0% | 0% | $6,174 |
| NATIONAL BANK OF CANADA /FI/ | 0% | 13 | 0% | 0% | $394 |
| Tower Research Capital LLC (TRC) | 0% | 1 | 0% | $31 | |
| CITIGROUP INC | 0% | 1 | 0% | $31 | |
| MILLENNIUM MANAGEMENT LLC | 0% | 0 | -100% | $0 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 5,698,109 | $175,900,273 | +$46,423 | $30.87 | 15 |
| 2025 Q4 | 5,700,886 | $131,804,789 | +$1,261,855 | $23.12 | 14 |
| 2025 Q3 | 5,644,984 | $106,633,384 | +$3,288 | $18.89 | 11 |
| 2025 Q2 | 5,645,042 | $25,554,914 | -$414,807 | $4.73 | 8 |
| 2025 Q1 | 5,761,181 | $20,624,582 | -$1,004,115 | $3.58 | 10 |
| 2024 Q4 | 6,067,225 | $17,419,035 | -$1,000,406 | $2.87 | 16 |
| 2024 Q3 | 6,417,922 | $36,903,052 | -$14,323,739 | $5.75 | 9 |
| 2024 Q2 | 9,293,451 | $46,466,940 | -$68,645 | $5.00 | 11 |
| 2024 Q1 | 9,306,982 | $59,748,622 | +$230,299 | $6.50 | 11 |
| 2023 Q4 | 9,271,406 | $67,496,071 | +$33,478,773 | $7.28 | 12 |
| 2023 Q3 | 4,468,338 | $39,097,959 | +$8,789,679 | $8.75 | 9 |
| 2023 Q2 | 3,463,804 | $17,715,486 | +$5,090 | $5.07 | 5 |
| 2023 Q1 | 3,462,800 | $12,353,370 | -$3,852 | $3.52 | 4 |
| 2022 Q4 | 3,463,881 | $12,194,444 | +$2,929 | $3.67 | 5 |
| 2022 Q3 | 3,463,083 | $12,218,000 | -$49,000 | $3.54 | 5 |
| 2022 Q2 | 3,476,092 | $13,278,000 | -$18,904 | $3.78 | 6 |
| 2022 Q1 | 3,481,131 | $25,974,000 | -$293,544 | $7.25 | 6 |
| 2021 Q4 | 3,520,885 | $28,772,000 | -$6,268,938 | $8.10 | 7 |
| 2021 Q3 | 4,094,109 | $46,466,000 | -$10,429,241 | $11.36 | 9 |
| 2021 Q2 | 4,852,401 | $66,866,000 | -$203,431 | $13.78 | 10 |
| 2021 Q1 | 4,867,161 | $73,173,000 | -$987,342 | $15.04 | 10 |
| 2020 Q4 | 4,926,653 | $81,291,000 | +$81,291,000 | $16.50 | 11 |